May 6, 2022 News by Lindsey Shapiro, PhD MS May Influence Timely Cancer Screenings, Diagnosis: Study Breast cancer is less likely to be detected through a routine cancer screening for women withĀ multiple sclerosis (MS), while colorectal cancer is more likely to be detected at an early stage in MS patients compared with those without the disease, a Canadian study found. āUnderstanding the pathways to earlier…
January 12, 2022 News by Yedida Y Bogachkov PhD MS Patients at Greater Cancer Risk for Reasons That Include Lifestyle People with multiple sclerosis (MS) are at greater risk of developing cancer than the general population, according to a French study involving nearly 100,000 patients. This increased risk was particularly apparent for prostate, breast, colorectal, and anal cancers, as well as cancers of the trachea, bronchus, and lung.Ā The researchers…
May 24, 2021 News by Marta Figueiredo, PhD MS May Not Affect Breast Cancer Survival, Study Suggests Women with multiple sclerosisĀ (MS)Ā diagnosed with breast cancer are not at a higher risk of dying from cancer than women without the neurodegenerative disorder, according to a Canadian population-based study. However, 10 years after their breast cancer diagnosis, women with MS were 28% more likely to die from any…
December 1, 2020 News by Marta Figueiredo, PhD MS Patients at Higher Risk of Bladder Cancer, But Not Breast, Colorectal Cancer People with multiple sclerosisĀ (MS) are at a higher risk of developing and dying from bladder cancer than people without the neurodegenerative disorder, according to a Canadian population-based study. However, no differences were found between MS patients and unaffected individuals in terms of their risk of breast and…
October 11, 2018 News by Jose Marques Lopes, PhD #ECTRIMS2018 – Rituximab for MS Does Not Increase Cancer Risk Compared to Gilenya and Tysabri, Swedish Study Finds Treatment of multiple sclerosis (MS) patients with rituximab does not increase breast cancer risk in women, and is not associated with a higher risk for malignant cancer of any type in men or women, when compared to Gilenya (fingolimod) orĀ Tysabri (natalizumab), according to a nationwide study in…
November 1, 2016 News by Joana Fernandes, PhD MS Does Not Raise a Women’s Risk of Breast Cancer, Study Concludes Multiple sclerosis (MS), especially in premenopausal women,Ā does Ā not seem to be associated with breast cancer, as suggested in previous studies, researchers reported. And, they argue,Ā theĀ higher incidences of this cancer in postmenopausal women with MS may be due more toĀ surveillance bias than true risk. These findings were detailedĀ in the study, ā…
September 7, 2016 News by Joana Fernandes, PhD Breast Cancer Therapy, Tamoxifen, May Promote Myelin Repair in MS Tamoxifen (brand name, Nolvadex), a widely used treatment for breast cancer, can also be used to treat myelin loss in patients with multiple sclerosis (MS), a new study suggests. The finding, by a team of researchers at the University of Cambridge, U.K., was published in a study titled “…